Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis

Lin XL, Xiao Liang Lin, Hai N, Ning Hai, Zhang J, Jing Zhang, Zhiyu Han, Zhi Yu Han, Han ZY, Jie Yu, Yu J, Liu FY, Fang Yi Liu, Xue Juan Dong, Dong XJ, Ping Liang, Liang P
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2020 · vol. 37(1) , pp. 151–156 · doi:10.1080/02656736.2019.1708481 · PMID:32024402 · W3005359517
Non-randomised trial OA: gold CC0 ⤵ 20 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Both microwave ablation and radiofrequency ablation effectively treated symptomatic uterine adenomyosis, with microwave ablation showing a shorter mean ablation time.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objectives: To prospectively compare the effectiveness and safety of percutaneous microwave ablation (PMWA) and ultrasound-guided radiofrequency ablation (USgRFA) for treating symptomatic uterine adenomyosis.Methods: One hundred and thirty-three women with symptomatic uterine adenomyosis who met the inclusion criteria were enrolled in our study from October 2015 to October 2017. Sixty-eight patients underwent PMWA, and sixty-five patients underwent USgRFA. All patients were followed up for 12 months. Assessment endpoints included treatment time, percentage ablation, percentage uterine regression, symptom severity scores (SSSs), dysmenorrhea scores and adverse events.Results: The mean age of the patients in our study was 39.4 ± 4.2 years (range, 35-50 years), and the median volume of uterine adenomyosis was 124.3 cm3 (range, 28.7-374.5 cm3). The mean ablation time was 16.3 ± 4.9 min (range, 5-23 min) in the MWA group, which was demonstrably superior to that of the RFA group, which was 37.5 ± 6.2 min (range, 5-39 min). The mean percentages of ablation of uterine adenomyosis were 79.7 ± 15.1% and 79.2 ± 14.2% in the MWA group and the RFA group, respectively, and showed no significant difference between the groups. The percentages of regression of uterine volume also showed no marked difference between the two groups. Changes in the dysmenorrhea scores and the SSSs after ablation were similar in the MWA group and in the RFA group, and no significant difference was found between the groups. Finally, the percentage occurrence of adverse events was the same in the two groups.Conclusions: The safety and effectiveness of PMWA and USgRFA in the treatment of uterine adenomyosis were similar; however, the mean ablation time of PMWA was shorter than that of USgRFA.

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Catheter Ablation High-Intensity Focused Ultrasound Ablation Uterine Neoplasms Adenomyosis Adenomyosis Adult Adult Catheter Ablation Catheter Ablation Female Female High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Humans Middle Aged Middle Aged Prospective Studies Prospective Studies

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (40)

Cited by (21)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:26:34.481680+00:00
License: CC0 · commercial use OK